Cargando…

Reappraisal of Coronavirus Disease 2019 Risk for Patients With Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid

Detalles Bibliográficos
Autores principales:	Ungaro, Ryan C., Kappelman, Michael D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the AGA Institute. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514020/ https://www.ncbi.nlm.nih.gov/pubmed/36162590 http://dx.doi.org/10.1053/j.gastro.2022.09.015

Ejemplares similares

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
por: Lamb, Christopher Andrew, et al.
Publicado: (2019)

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
por: Kennedy, Nicholas A, et al.
Publicado: (2020)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement
por: Alexander, James L, et al.
Publicado: (2021)

British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance
por: Churchhouse, Antonia MD, et al.
Publicado: (2023)

Anti-TNF Withdrawal in Inflammatory Bowel Disease
por: Torres, Joana, et al.
Publicado: (2016)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE
por: Spiera, Emily, et al.
Publicado: (2022)

Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease
por: Parekh, Rajen, et al.
Publicado: (2021)

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions
por: Ungaro, Ryan C., et al.
Publicado: (2021)

Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2021)

Working Together to Meet the Needs of Patients With Inflammatory Bowel Diseases
por: Brenner, Erica J., et al.
Publicado: (2021)

Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease
por: Louis, Edouard
Publicado: (2020)

Risk of cardiovascular disease in inflammatory bowel disease
por: Wu, Ping, et al.
Publicado: (2017)

Unmet needs in inflammatory bowel disease
por: Revés, Joana, et al.
Publicado: (2021)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020)

The Technical Quality of Delivered Care for People with Inflammatory Bowel Disease in Tabriz Gastroenterology Clinics
por: Tabrizi, Jafar Sadegh, et al.
Publicado: (2015)

Improvement of Osteoporosis Screening among Inflammatory Bowel Disease Patients at Gastroenterology Fellows' Clinics
por: Wehbeh, Antonios, et al.
Publicado: (2020)

Gastroenterology team members’ knowledge and practices with fertility therapy for women with inflammatory bowel disease
por: Laube, Robyn, et al.
Publicado: (2022)

Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021)

Risk of thrombosis and mortality in inflammatory bowel disease
por: Andrade, Adriana R., et al.
Publicado: (2018)

Psoriasis and inflammatory bowel disease: links and risks
por: Vlachos, Christoforos, et al.
Publicado: (2016)

Familial and ethnic risk in inflammatory bowel disease
por: Santos, Maria Pia Costa, et al.
Publicado: (2018)

The risk of cardiovascular complications in inflammatory bowel disease
por: Czubkowski, Piotr, et al.
Publicado: (2020)

Inflammatory Bowel Disease and the Risk of Herpes Zoster
por: Lai, Shih-Wei
Publicado: (2019)

Cardiovascular Risk in Individuals with Inflammatory Bowel Disease
por: Biondi, Robertha Baccaro, et al.
Publicado: (2020)

Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2022)

Environmental risk factors for inflammatory bowel disease
por: Singh, Noreen, et al.
Publicado: (2022)

Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
por: Papa, Alfredo, et al.
Publicado: (2021)

The Bowel Microbiota and Inflammatory Bowel Diseases
por: Tannock, Gerald W.
Publicado: (2010)

COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology
por: Tse, Frances, et al.
Publicado: (2021)

Impact of a nurse navigator on a dedicated inflammatory bowel disease-focused gastroenterology clinic
por: Maheshwari, Parth, et al.
Publicado: (2021)

Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?
por: Bernasko, Nana, et al.
Publicado: (2021)

Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
por: Halling, Morten L, et al.
Publicado: (2017)

Inflammatory bowel disease /
Publicado: (2000)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Inflammatory Bowel Disease
por: Lee, Shona J., et al.
Publicado: (2014)

Inflammatory Bowel Disease
por: Nasseri-Moghaddam, Siavosh
Publicado: (2012)

Inflammatory Bowel Disease
Publicado: (2013)

INFLAMMATORY BOWEL DISEASE
por: Johns, Alice J.
Publicado: (2001)

Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome
por: Porter, Chad K, et al.
Publicado: (2012)

Clinical Features and Outcomes of Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease and Spondyloarthropathies
por: Tozlu, Mukaddes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s6b6mf0ljap5j3ptvt1qc9jp1q